204 related articles for article (PubMed ID: 35588276)
1. Effective Interferon Lambda Treatment Regimen To Control Lethal MERS-CoV Infection in Mice.
Dijkman R; Verma AK; Selvaraj M; Ghimire R; Gad HH; Hartmann R; More S; Perlman S; Thiel V; Channappanavar R
J Virol; 2022 Jun; 96(11):e0036422. PubMed ID: 35588276
[TBL] [Abstract][Full Text] [Related]
2. IFN-λ drives distinct lung immune landscape changes and antiviral responses in human metapneumovirus infection.
Sojati J; Parks OB; Zhang Y; Walters S; Lan J; Eddens T; Lou D; Fan L; Chen K; Oury TD; Williams JV
mBio; 2024 May; 15(5):e0055024. PubMed ID: 38530032
[TBL] [Abstract][Full Text] [Related]
3. Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19.
Park A; Iwasaki A
Cell Host Microbe; 2020 Jun; 27(6):870-878. PubMed ID: 32464097
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of SARS-CoV-2 by type I and type III interferons.
Felgenhauer U; Schoen A; Gad HH; Hartmann R; Schaubmar AR; Failing K; Drosten C; Weber F
J Biol Chem; 2020 Oct; 295(41):13958-13964. PubMed ID: 32587093
[TBL] [Abstract][Full Text] [Related]
5. MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells.
Cong Y; Hart BJ; Gross R; Zhou H; Frieman M; Bollinger L; Wada J; Hensley LE; Jahrling PB; Dyall J; Holbrook MR
PLoS One; 2018; 13(3):e0194868. PubMed ID: 29566060
[TBL] [Abstract][Full Text] [Related]
6. Potent Antiviral Activity of Vitamin B12 against Severe Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory Syndrome Coronavirus, and Human Coronavirus 229E.
Moatasim Y; Kutkat O; Osman AM; Gomaa MR; Okda F; El Sayes M; Kamel MN; Gaballah M; Mostafa A; El-Shesheny R; Kayali G; Ali MA; Kandeil A
Microorganisms; 2023 Nov; 11(11):. PubMed ID: 38004788
[TBL] [Abstract][Full Text] [Related]
7. Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures.
Chan RW; Chan MC; Agnihothram S; Chan LL; Kuok DI; Fong JH; Guan Y; Poon LL; Baric RS; Nicholls JM; Peiris JS
J Virol; 2013 Jun; 87(12):6604-14. PubMed ID: 23552422
[TBL] [Abstract][Full Text] [Related]
8. Broad-spectrum antiviral activity of two structurally analogous CYP3A inhibitors against pathogenic human coronaviruses in vitro.
Gallucci L; Bazire J; Davidson AD; Shytaj IL
Antiviral Res; 2024 Jan; 221():105766. PubMed ID: 38042417
[TBL] [Abstract][Full Text] [Related]
9. Interferon signaling in the nasal epithelium distinguishes among lethal and common cold coronaviruses and mediates viral clearance.
Otter CJ; Renner DM; Fausto A; Tan LH; Cohen NA; Weiss SR
Proc Natl Acad Sci U S A; 2024 May; 121(21):e2402540121. PubMed ID: 38758698
[TBL] [Abstract][Full Text] [Related]
10. IFN-λ1 Displays Various Levels of Antiviral Activity In Vitro in a Select Panel of RNA Viruses.
Plotnikova M; Lozhkov A; Romanovskaya-Romanko E; Baranovskaya I; Sergeeva M; Kаа K; Klotchenko S; Vasin A
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452467
[TBL] [Abstract][Full Text] [Related]
11. Comparative transcriptome analysis of SARS-CoV-2, SARS-CoV, MERS-CoV, and HCoV-229E identifying potential IFN/ISGs targets for inhibiting virus replication.
Liu Y; Lu T; Li C; Wang X; Chen F; Yue L; Jiang C
Front Med (Lausanne); 2023; 10():1267903. PubMed ID: 38143441
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells.
Santer DM; Minty GES; Golec DP; Lu J; May J; Namdar A; Shah J; Elahi S; Proud D; Joyce M; Tyrrell DL; Houghton M
PLoS Pathog; 2020 Apr; 16(4):e1008515. PubMed ID: 32353085
[TBL] [Abstract][Full Text] [Related]
13. Roles of Type I and III Interferons in COVID-19.
Choi H; Shin EC
Yonsei Med J; 2021 May; 62(5):381-390. PubMed ID: 33908208
[TBL] [Abstract][Full Text] [Related]
14. Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays.
Hart BJ; Dyall J; Postnikova E; Zhou H; Kindrachuk J; Johnson RF; Olinger GG; Frieman MB; Holbrook MR; Jahrling PB; Hensley L
J Gen Virol; 2014 Mar; 95(Pt 3):571-577. PubMed ID: 24323636
[TBL] [Abstract][Full Text] [Related]
15. A Systematic Review of therapeutic agents for the treatment of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
Momattin H; Al-Ali AY; Al-Tawfiq JA
Travel Med Infect Dis; 2019; 30():9-18. PubMed ID: 31252170
[TBL] [Abstract][Full Text] [Related]
16. Induction of antiviral gene expression by cyclosporine A, but not inhibition of cyclophilin A or B, contributes to its restriction of human coronavirus 229E infection in a lung epithelial cell line.
Mamatis JE; Gallardo-Flores CE; Sangwan U; Tooley TH; Walsh T; Colpitts CC
Antiviral Res; 2023 Nov; 219():105730. PubMed ID: 37805057
[TBL] [Abstract][Full Text] [Related]
17. IL-37 possesses both anti-inflammatory and antiviral effects against Middle East respiratory syndrome coronavirus infection.
Qi F; Yan Y; Lv Q; Liu M; Liu M; Li F; Deng R; Liang X; Li S; Mou G; Bao L
Animal Model Exp Med; 2024 May; ():. PubMed ID: 38803038
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of current medical approaches for Middle East respiratory syndrome: A systematic review and meta-analysis.
Morra ME; Van Thanh L; Kamel MG; Ghazy AA; Altibi AMA; Dat LM; Thy TNX; Vuong NL; Mostafa MR; Ahmed SI; Elabd SS; Fathima S; Le Huy Vu T; Omrani AS; Memish ZA; Hirayama K; Huy NT
Rev Med Virol; 2018 May; 28(3):e1977. PubMed ID: 29664167
[TBL] [Abstract][Full Text] [Related]
19. Bovine Interferon Lambda Is a Potent Antiviral Against SARS-CoV-2 Infection
Cardoso NP; Mansilla FC; Benedetti E; Turco CS; Barone LJ; Iserte JA; Soria I; Baumeister E; Capozzo AV
Front Vet Sci; 2020; 7():603622. PubMed ID: 33240967
[TBL] [Abstract][Full Text] [Related]
20. Fangchinoline inhibits SARS-CoV-2 and MERS-CoV entry.
Sadhu S; Dandotiya J; Dalal R; Khatri R; Mykytyn AZ; Batra A; Kaur M; Chandwaskar R; Singh V; Kamboj A; Srivastava M; Mani S; Asthana S; Samal S; Rizvi ZA; Salunke DB; Haagmans BL; Awasthi A
Antiviral Res; 2023 Dec; 220():105743. PubMed ID: 37949319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
